Skin Lightening With Emblica™ (O/W) MDA-A-155-01

Merck KGaA
Phase
Product
INCI Name
Supplier
Volume
A
RonaFlair® Boroneige® SF-3
BORON NITRIDE
1
5.00
Tego Care 215
GLYCERYL STEARATE, CETEARETH-15
2
2.50
Cetiol V
DECYL OLEATE
3
7.00
Mirasil DM 350
DIMETHICONE
4
0.50
Lanette 18
STEARYL ALCOHOL
3
2.00
Carbopol ETD 2050
CARBOMER
5
0.20
Isopropyl Palmitate
Isopropyl Palmitate
3
7.00
B
Glycerol 85%
GLYCERIN, AQUA (WATER)
1
3.00
Titriplex® III
DISODIUM EDTA
1
0.10
Water, demineralized
63.20
C
Emblica™
PHYLLANTHUS EMBLICA FRUIT EXTRACT
1
2.00
Preservatives
qs
Water, demineralized
5.00
D
Sodium Hydroxide, 10%
AQUA (WATER), SODIUM HYDROXIDE
1
1.50

Preparation:

Prepare phase A without Boroneige SF- 3. Heat phases A and B separately to 80°C. Disperse Boroneige SF-3 into the oil phase A with a dissolver stirrer. Add phase A to phase B while stirring. Disperse Emblica in water and add phase C to A/B under 40°C. Neutralize with phase D. Homogenize. Add phases E and cool down while stirring.

Notes:

pH value (23°C) : 5.40Viscosity : 40 000 mPa.s (Brookfield DV-II+, Helipath, spindle C, 10 rpm, Helipath) at 23°CAppearance: beige emulsion (1) Merck KGaA, Darmstadt, Germany / EMD Chemicals (2) Evonik Goldschmidt GmbH (3) BASF AG (4) Rhodia GmbH (5) Lubrizol (6) Schülke & Mayr GmbH
Disclaimer

While every effort has been made to reproduce these formulations correctly, the Publisher of this website cannot accept any liability for the information presented. All formulations are provided in good faith, but no warranty is given as to accuracy of information or results, or suitability for a particular use, nor is freedom from patent infringement to be inferred. Formulations are offered solely for consideration by the participating manufacturers. Continued use of this web site infers acceptance of this disclaimer.

Latest Issues

IFSCC 2024

Recanto das Cataratas Thermas Resort, Iguazu Falls, Brazil
14th - 17th October 2024

SEPAWA

Estrel Congress Center, Berlin
16th - 18th October 2024